Glenn Sblendorio - Mar 25, 2022 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Signature
/s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio
Stock symbol
ISEE
Transactions as of
Mar 25, 2022
Transactions value $
-$265,103
Form type
4
Date filed
3/29/2022, 07:44 PM
Previous filing
Mar 22, 2022
Next filing
Apr 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $55.2K +18.8K +6.71% $2.94 298K Mar 25, 2022 Direct F1
transaction ISEE Common Stock Sale -$320K -18.8K -6.29% $17.06 280K Mar 25, 2022 Direct F1, F2
holding ISEE Common Stock 0 Mar 25, 2022 By trust for family member 1 F3
holding ISEE Common Stock 0 Mar 25, 2022 By trust for family member 2 F3
holding ISEE Common Stock 0 Mar 25, 2022 By trust for family member 3 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Stock Option (right to buy) Options Exercise $0 -18.8K -4.85% $0.00 368K Mar 25, 2022 Common Stock 18.8K $2.94 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021, as previously disclosed in the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on November 9, 2021.
F2 The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $17.00 to $17.28 per share on March 25, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F3 On December 23, 2021, the Reporting Person gifted a total of 60,000 shares of Registrant's common stock to three trusts of which the Reporting Person's immediate family members are the sole trustees and sole beneficiaries. The Reporting Person reported these shares as indirectly owned following the gifts and disclaimed beneficial ownership. As of March 26, 2022, the Reporting Person no longer shares a primary residence with any of the trustees or beneficiaries of these trusts and no longer has a reportable beneficial interest in these shares.
F4 This stock option award was granted on December 19, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.